NewGenIvf Group Limited
NIVF
$0.63
$0.034.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 282.80% | 282.80% | -132.24% | -119.41% | -28.85% |
| Total Depreciation and Amortization | -171.76% | -171.76% | 7.72% | 122.46% | -83.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -131.82% | -131.82% | -704.14% | 86.56% | -33.33% |
| Change in Net Operating Assets | -135.04% | -135.04% | -649.24% | -4,295.31% | 402.86% |
| Cash from Operations | -121.26% | -121.26% | -2,610.12% | -4,804.20% | 347.22% |
| Capital Expenditure | -511.54% | -511.54% | 84.57% | 23.85% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -747,820.00% | -747,820.00% | -- | -- | -- |
| Cash from Investing | -66,064.91% | -66,064.91% | 178.29% | -5.53% | -- |
| Total Debt Issued | 154.46% | 154.46% | 1,110.69% | -175.42% | -- |
| Total Debt Repaid | -- | -- | 2,629.79% | -2,629.79% | 31.91% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.22% | 99.22% | -226.47% | 580.94% | -580.93% |
| Cash from Financing | 328.88% | 328.88% | 1,583.91% | 4,020.10% | -354.00% |
| Foreign Exchange rate Adjustments | -231.69% | -231.69% | 130.03% | -652.44% | 633.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 785.23% | 785.23% | 1,594.71% | 64.18% | 161.04% |